Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2021GlobeNewsWire • 08/11/20
Medtronic Announces Comprehensive U.S. Launch of New InterStim™ Micro NeurostimulatorGlobeNewsWire • 08/05/20
Medtronic Expands Leadership in Treating Bladder and Bowel Control Conditions with Two New FDA-Approved Products: InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI LeadsGlobeNewsWire • 08/03/20
Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks24/7 Wall Street • 07/28/20
Medtronic Foundation Commits $16M in Health and Education Partnerships to Address Racial Disparities and Advance Social Justice in Black CommunitiesGlobeNewsWire • 07/22/20
Why These Top Medical Device Stocks Have Fallen by Double Digits So Far in 2020The Motley Fool • 07/11/20
2 Big Mergers: One a $4 Billion Cash Deal, the Other Still in the Rumor Mill 24/7 Wall Street • 07/08/20
Medtronic Gains FDA Clearance, CE Mark for LINQ II™ Insertable Cardiac Monitor (ICM)GlobeNewsWire • 07/07/20
Medtronic Introduces MiniMed™ Mio™ Advance Infusion Set Enabling Fewer Insertion Steps for People with Diabetes in the U.S.GlobeNewsWire • 07/07/20